CPT 80330 Reimbursement & Policy Benchmarks

CPT code 80330 denotes a multianalyte toxicology assay that detects or measures three to five nonopioid analgesics in a patient specimen. Nationally, this code supports clinical management of pain and medication monitoring, informs medication reconciliation, and underpins laboratory billing for common nonopioid pain agents. The code matters because laboratory utilization for drug panels affects payer coverage policies, prior authorization workflows, and clinical decision-making across acute and ambulatory care settings.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical purpose of the test, typical sites of service, and how this code is categorized within laboratory service billing. The publication provides benchmarks and policy context relevant to laboratory and payer interactions, summarizes common modifiers associated with laboratory billing, and outlines practical coding relationships. It also highlights areas where payers may apply medical necessity criteria or require documentation for laboratory drug testing panels.

This summary is written for a national audience and frames 80330 within clinical workflows and payer practices without reference to state-specific rules.

Billing Code Overview

CPT code 80330 describes a laboratory test in which the lab analyst measures the amount of or detects the presence of three to five nonopioid analgesics (pain medications) in a patient specimen. This service is a multianalyte toxicology panel for nonopioid analgesics used to identify and quantify commonly prescribed or over-the-counter pain medications.

Service type: Clinical laboratory testing (multianalyte toxicology analysis)
Typical site of service: Clinical laboratory or hospital laboratory; specimens are collected in ambulatory clinics, hospitals, or outpatient laboratory collection centers.

Data not available in the input.

Clinical Context

A 38-year-old outpatient with chronic musculoskeletal pain controlled with nonopioid analgesics presents for routine monitoring and suspected subtherapeutic levels after dose adjustment. The clinician orders a urine or plasma drug assay to detect or quantify multiple nonopioid analgesics to verify adherence and guide medication management. Specimen collection occurs in an outpatient laboratory or hospital outpatient clinic; the specimen is sent to a clinical chemistry/toxicology laboratory where a lab analyst performs a multi-analyte assay measuring three to five nonopioid analgesics (e.g., acetaminophen, ibuprofen, naproxen, diclofenac, celecoxib). Results are reported to the prescribing provider, and the laboratory documents specimen source, collection time, test method, analyte panel, and quantitative or qualitative findings in the electronic medical record.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the professional interpretation component of the test separated from the technical component.
`TC`	Technical component	Use when billing only the technical component (laboratory processing and equipment) without professional interpretation.

Taxonomy Code	Specialty	Notes
207RH0000X	Clinical Pathology	Pathologists overseeing laboratory testing and interpretation for toxicology/chemistry assays.
2080P0106X	Medical Clinical	Pain management physicians ordering and interpreting multi-analtye analgesic testing.
207L00000X	Anatomic and Clinical Pathology	Laboratory directors supervising quality and result validation.
2084P0800X	Emergency Medicine	ED clinicians may order rapid multi-analyte analgesic testing for acute presentations.
261QM2500X	Clinical Laboratory Science/Medical Technology	Medical technologists performing specimen analysis in the laboratory.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`G89.3`	Neoplasm related pain (acute)	Nonopioid analgesic panels may be ordered for cancer-related pain management when nonopioid agents are used.
`G89.4`	Chronic pain syndrome	Common indication for monitoring nonopioid analgesic therapy and adherence.
`M54.5`	Low back pain	Typical musculoskeletal pain condition managed with nonopioid analgesics and monitored with multi-analyte testing.
`M25.5`	Pain in joint	Joint pain managed with NSAIDs where therapeutic monitoring or adherence verification may be needed.
`R52`	Pain, unspecified	General pain complaints for which a provider may order multi-analyte nonopioid analgesic testing to guide treatment.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80305`	Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, capable of being read by direct optical observation only (e.g., dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of service	Performed at point-of-care or in the lab as an initial screen prior to sending a specimen for confirmatory multi-analtye testing.
`80307`	Drug test(s), presumptive, any number of drug classes; instrumented analyzers, non-OTC	Used for instrumented screening that may precede or complement definitive multi-analyte nonopioid analgesic assays.
`80320`	Drug test(s), definitive, qualitative, non-therapeutic drug(s), any number of drug classes; e.g., gas chromatography/mass spectrometry (GC/MS)	Definitive confirmatory testing for identified analgesics when qualitative confirmation is required.
`80321`	Drug test(s), definitive, quantitative, non-therapeutic drug(s), any number of drug classes; e.g., GC/MS	Quantitative confirmation of specific analgesic concentrations when clinician needs exact levels.
`81002`	Urinalysis, non-automated, without microscopy	Specimen evaluation that may be performed prior to or alongside urine drug testing for specimen validity.

OpenPayer

Summary & Overview

CPT 80330: Multianalyte Toxicology Panel for 3–5 Nonopioid Analgesics